Table 1 The clinical features of STAD patients in training cohort and validation cohort
From: Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
Character | Training cohort | Entire cohort | p value |
|---|---|---|---|
n = 158 | n = 319 | ||
Age(year) | |||
 ≥ 65 | 94(59.50%) | 181(56.74%) | 0.623 |
 <65 | 64(40.50%) | 138(43.26%) |  |
Gender | |||
 Female | 59(37.34%) | 115(36.05%) | 0.840 |
 Male | 99(62.66%) | 204(63.95%) |  |
TNM Stage | |||
 I-II | 71(44.94%) | 150(47.02%) | 0.697 |
 III-IV | 87(55.06%) | 169(52.98%) |  |
T stage | |||
 T1-T2 | 41(25.95%) | 81(25.39%) | 0.911 |
 T3-T4 | 117(74.05%) | 238(74.61%) |  |
M stage | |||
 M1 | 8(5.06%) | 21(6.58%) | 0.684 |
 M0-Mx | 150(94.94%) | 298(93.42%) |  |
N stage | |||
 N0-N1 | 87(55.06%) | 182(57.05%) | 0.696 |
 N2-N3 | 71(44.94%) | 137(42.95%) |  |
Futime | |||
Survival status | |||
 Alive | 106(67.09%) | 205(64.26%) | 0.610 |
 Dead | 52(32.91%) | 114(35.74%) |  |